(Formerly known as Central Clinical School)
 |
| Progestin based hormonal contraceptive pills can tip vulnerable women into depression, review shows |
by Anne Crawford
For some time, Monash Central Clinical School psychiatrist Professor Jayashri Kulkarni has treated women telling her they had developed depression since being prescribed certain oral contraception or that their existing depression had become out of control.
 |
| L-R: Ms Nurul Abidin Zainal, Dr Warwick Nesbitt and Dr Crispin Szydzik are authors on the paper |
The team includes Australian Centre for Blood Diseases (ACBD) researchers, in collaboration with Alfred Health, University of Melbourne (Engineering & Medicine) and RMIT University (Engineering).
 |
| A systematic review of perioperative clinical trials in Australia found there was very little consumer engagement in formulation, management, conduct and dissemination of the trial findings. |
The most recent validated publications for the school and departments can be seen on their publications pages, linked to from the headings below. Otherwise, read down the entry for recent notifications. The below is not a comprehensive list.
 |
| L-R: Prof Kit Fairley, A/Prof Eric Chow, Prof Marcus Chen, Prof Jane Hocking, Prof Deborah Williamson, Prof Catriona Bradshaw |
The Eureka Prizes honour excellence across the areas of research and innovation, leadership, science engagement and school science, and are presented annually in partnership with some of the country’s leading scientific institutions, government organisations, universities and corporations.
See all four Monash MNHS finalists shortlisted for the 2022 Australian Museum Eureka Prizes in the faculty story and MSHC detail below.
 |
The de Castella Run, which the Monash Alfred Psychiatry research centre helped organise in previous years, is raising funds for One in Five. One in Five are supporting the newly established HER Centre Australia. If you can support this event by volunteering, running or walking for mental health at the event on 28 August, go to the website and sign up as a participant.
 |
| L-R: Dr Keith Al-Hasani, Dr Ishant Khurana and Professor Sam El-Osta, lead authors on the beta cell regeneration study. Ishant Khurana explains more about the research in a video (1:02 mins) and see animation |
In a world-first, a study by Monash University has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.
Using the pancreas stem cells of type 1 diabetic donor, researchers were able to effectively reactivate them to become insulin-expressing and functionally resemble beta-like cells through the use of a drug which is approved by the US Food and Drug Administration but is not currently licensed for diabetes treatment.
The new approach, though it requires further work, would in principle allow insulin-producing cells (beta-cells) that are destroyed in type 1 diabetics to be replaced with newborn insulin-generating cells.
 |
| Dr Emily Edwards has received an ASPIRE award |
Congratulations to Dr Emily Edwards for winning the ASPIRE award presented by Grifols. The ASPIRE (Award for Scientific Progress in Immunodeficiency Research) Award program is particularly interested in innovative ideas in the field of primary and secondary immunodeficiencies and the role of immunoglobulin therapy.
As part of this prestigious international award, Emily will receive €50,000 for her project, "Advancing the Genetic Diagnosis of Predominantly Antibody Deficiency through Development and Implementation of Functional Diagnostic Screening Assays."
The project will support Emily's ongoing work in collaboration with Dr Julian Bosco and Prof Robyn O'Hehir (Alfred Health), Dr Samar Ojaimi (Monash Health), Dr Jason Fok (Eastern Health) and A/Prof Menno van Zelm (Monash University), and will be awarded at the ESID conference in Gothenburg, Sweden in October.
